Big Pharma’s Big Bankroll Beginning To Bolster Biotech

As venture capitalists pull back on their funding for life sciences, Big Pharma is flexing its considerable financial muscle to grab up smaller biotech companies, providing an injection of capital that could translate into geographic expansion and more…